SEI INVESTMENTS CO

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 350894 OAKS, PA

Position in APLS

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

+$0 QoQ

Shares Held

11,747

-80.5% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

17 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SEI INVESTMENTS CO holds $1,244,853,717 across 210 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	255,073	$236,649,076
2	INSM	INSMED Inc	1,015,870	$108,312,059
3	VRTX	Vertex Pharmaceuticals Inc / Ma	129,981	$64,565,461
4	EXEL	Exelixis, Inc.	1,166,715	$63,480,962
5	ASND	Ascendis Pharma A/S	237,869	$63,444,419
6	INCY	Incyte Corp	498,013	$56,454,752
7	HALO	Halozyme Therapeutics, Inc.	551,116	$43,135,848
8	REGN	Regeneron Pharmaceuticals, Inc.	60,441	$37,687,380

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	—	11,747	-80.5%	Shares	Sole	2026-05-13
2025-12-31	—	60,291	-61.1%	Shares	Sole	2026-02-13
2025-09-30	—	155,122	+593.8%	Shares	Sole	2025-11-13
2025-06-30	—	22,359	-25.9%	Shares	Sole	2025-08-14
2024-09-30	—	30,155	-13.0%	Shares	Sole	2024-11-12
2024-06-30	—	34,666	-13.0%	Shares	Sole	2024-08-13
2024-03-31	—	39,864	+57.4%	Shares	Sole	2024-05-07
2023-12-31	—	25,333	-22.5%	Shares	Sole	2024-02-14
2023-09-30	—	32,673	-50.0%	Shares	Sole	2023-11-14
2023-06-30	—	65,335	+27.6%	Shares	Defined	2023-08-11
2023-03-31	—	51,195	+374.2%	Shares	Sole	2023-05-12
2022-12-31	—	10,796	-80.7%	Shares	Sole	2023-02-10
2022-09-30	—	55,921	+184.2%	Shares	Defined	2022-11-14
2021-06-30	—	19,674	+20.9%	Shares	Defined	2021-08-06
2021-03-31	—	16,268	0.0%	Shares	Defined	2021-05-12
2020-12-31	—	16,268	+109.0%	Shares	Defined	2021-02-08
2020-03-31	—	7,785	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.